When to Test for Infectious Mononucleosis
Test for infectious mononucleosis when patients aged 10-30 years present with sore throat and significant fatigue, especially if accompanied by posterior cervical or auricular lymphadenopathy, palatal petechiae, or marked adenopathy. 1
Clinical Indications for Testing
High-Suspicion Clinical Features
Test when patients present with the classic triad of:
- Fever, tonsillar pharyngitis, and lymphadenopathy 2, 3
- Significant fatigue that is disproportionate to other symptoms 1
- Posterior cervical or auricular adenopathy (more specific than anterior cervical nodes) 1
- Palatal petechiae 1
- Periorbital or palpebral edema (occurs in one-third of patients) 2
Age-Specific Considerations
- Primary target age: 15-24 years (most commonly affected) 2, 3
- Broader testing range: 10-30 years when clinical features are present 1
- Be aware that heterophile antibody tests have higher false-negative rates in children younger than 5 years 3
Initial Laboratory Testing Approach
First-Line Testing
Order a complete blood count with differential and rapid heterophile antibody test (Monospot) as the initial cost-effective approach 3:
CBC findings supporting diagnosis:
Heterophile antibody test characteristics:
Common Pitfalls with Heterophile Testing
False-positive heterophile results may occur in patients with:
False-negative heterophile results are common in:
- Children younger than 10 years (approximately 10% false-negative rate overall) 4
- Early infection (first week of symptoms) 1, 3
When to Proceed with EBV-Specific Serologic Testing
Order EBV serologic testing when clinical suspicion remains high despite a negative heterophile test 6, 5:
EBV Antibody Panel to Order
Test for the following three antibodies 4, 5:
- IgM antibodies to viral capsid antigen (VCA)
- IgG antibodies to VCA
- Antibodies to Epstein-Barr nuclear antigen (EBNA)
Interpretation of EBV Serology
- Recent primary EBV infection: VCA IgM present (with or without VCA IgG) AND EBNA antibodies absent 4, 5
- Past infection (>6 weeks): EBNA antibodies present, indicating infection is not recent 4, 5
- EBNA antibodies develop 1-2 months after primary infection and persist for life 4
- Note: 5-10% of EBV-infected patients fail to develop EBNA antibodies 4, 5
Additional Laboratory Findings
Elevated liver enzymes increase clinical suspicion for infectious mononucleosis when the heterophile test is negative 3
Differential Diagnosis Requiring Alternative Testing
When heterophile and EBV testing are negative, consider testing for other causes of mononucleosis-like illness 4, 5:
- Cytomegalovirus (CMV) infection 4, 5, 7
- HIV infection (perform opportunistic screening) 5, 7
- Toxoplasma gondii infection 4, 7
- Adenovirus infection 4, 5
- Streptococcal pharyngitis 7
Special Populations Requiring Testing
Immunocompromised Patients
Test immunocompromised patients more aggressively as they have increased risk of:
Consider EBV viral load testing by nucleic acid amplification in immunocompromised patients, particularly organ transplant recipients 4
Patients on Immunosuppressive Therapy
Screen for EBV status before initiating thiopurine therapy, particularly in pediatric IBD patients who are at higher risk from primary EBV infection 4
Testing NOT Recommended
Do not routinely perform EBV-specific antibody testing when: